Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Reference NMN (Nicotinamide Mononucleotide) 500mg FOR RESEARCH
Phase I Evidence Stage
Longevity Primary Domain
Oral administration; sublingual and injectable formulations also studied Routes Studied
150+ PubMed Citations
Longevity Peptide
Early-Stage Research

NMN (Nicotinamide Mononucleotide)

Synthetic peptide studied in animal and cell models for nad+ level restoration and mitochondrial function enhancement

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
NMN (Nicotinamide Mononucleotide)
Class
Longevity peptide
Summary
Synthetic peptide studied in animal and cell models for nad+ level restoration, mitochondrial function enhancement, metabolic and insulin sensitivity support.
Mechanism
Systemic Metabolic and Epigenetic Rejuvenation
Research Status
Phase I
Routes Studied
Oral administration; sublingual and injectable formulations also studied
Evidence Level
Early-stage research · Clinically unproven
[ QUICK.ANSWERS ]

What Should You Know About NMN (Nicotinamide Mononucleotide)?

What is NMN (Nicotinamide Mononucleotide)?
NMN (Nicotinamide Mononucleotide) is a synthetic peptide studied in animal and cell models for nad+ level restoration and mitochondrial function enhancement.
Is NMN (Nicotinamide Mononucleotide) clinically proven?
No. Human evidence remains limited and does not establish NMN (Nicotinamide Mononucleotide) as clinically proven.
What has NMN (Nicotinamide Mononucleotide) been studied for?
NMN (Nicotinamide Mononucleotide) has been studied in preclinical models of nad+ level restoration, mitochondrial function enhancement, metabolic and insulin sensitivity support. These findings have not been confirmed in large-scale human trials.
Is NMN (Nicotinamide Mononucleotide) approved?
No. NMN (Nicotinamide Mononucleotide) is not an approved drug and remains a research compound.
[ COMPOUND.PROFILE ]

What Is NMN (Nicotinamide Mononucleotide)?

Nicotinamide Mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), one of the most critical coenzymes in cellular metabolism. With the molecular formula C11H15N2O8P and a molecular weight of 334.22 g/mol, NMN is not a peptide but rather a nucleotide derivative composed of a nicotinamide group, a ribose sugar, and a phosphate group. It has emerged as one of the most intensively...

[ EVIDENCE.SUMMARY ]

Evidence Summary

Early-stage research · Clinically unproven

NMN (Nicotinamide Mononucleotide) has early-stage clinical data only. Safety data is emerging but efficacy evidence remains limited. Most claims exceed current clinical evidence.

Evidence Breakdown

Domain Evidence Level
NAD+ Level Restoration Limited
Mitochondrial Function Enhancement Limited
Metabolic and Insulin Sensitivity Support Limited
Vascular and Cardiovascular Health Limited
Human clinical evidence Limited
Safety data Insufficient

Editorial Position

NMN (Nicotinamide Mononucleotide) is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.

Regulatory Status Snapshot

  • Not approved as a therapeutic drug by major regulators
  • Safety profile not established in large human populations

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has NMN (Nicotinamide Mononucleotide) Been Studied For?

Research areas where NMN (Nicotinamide Mononucleotide) has been investigated in published studies

  • NAD+ Level Restoration NMN (Nicotinamide Mononucleotide) has been studied in animal models of nad+ level restoration. These findings have not been confirmed in controlled human trials.
  • Mitochondrial Function Enhancement NMN (Nicotinamide Mononucleotide) has been studied in animal models of mitochondrial function enhancement. These findings have not been confirmed in controlled human trials.
  • Metabolic and Insulin Sensitivity Support NMN (Nicotinamide Mononucleotide) has been studied in animal models of metabolic and insulin sensitivity support. These findings have not been confirmed in controlled human trials.
  • Vascular and Cardiovascular Health NMN (Nicotinamide Mononucleotide) has been studied in animal models of vascular and cardiovascular health. These findings have not been confirmed in controlled human trials.
[ MECHANISM ]

How Does NMN (Nicotinamide Mononucleotide) Work?

These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.

  1. 01 Cellular Uptake via Slc12a8 Transporter
  2. 02 NMNAT-Mediated NAD+ Synthesis
  3. 03 Downstream biological effect
  4. 04 Mitochondrial Electron Transport Chain Restoration
NEXT STEP

Not sure if NMN (Nicotinamide Mononucleotide) is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about NMN (Nicotinamide Mononucleotide).

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate NMN (Nicotinamide Mononucleotide)

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is NMN (Nicotinamide Mononucleotide) Administered?

NMN (Nicotinamide Mononucleotide) is available via Oral administration; sublingual and injectable formulations also studied. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of NMN (Nicotinamide Mononucleotide)?

Format Lyophilized Powder
Amount 500mg per vial
Purity >99%
Purity Method HPLC (High-Performance Liquid Chromatography)
Composition Beta-Nicotinamide Mononucleotide (beta-NMN), nucleotide
Molecular Weight 334.22 g/mol
Storage Store at -20°C for long-term storage. Protect from light and moisture. Short-term storage at 2-8°C acceptable.
Appearance White to slightly yellow crystalline powder
[ EXPLORE ]

What Conditions Has NMN (Nicotinamide Mononucleotide) Been Linked To?

Have Questions About NMN (Nicotinamide Mononucleotide)?

Extensive preclinical research in mice has demonstrated that NMN reverses multiple aging markers, including mitochondrial dysfunction, vascular stiffness, insulin resistance, reduced exercise capacity, and epigenetic drift.

Published studies on NMN (Nicotinamide Mononucleotide) can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

NMN (Nicotinamide Mononucleotide) is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.

Ready to discuss NMN (Nicotinamide Mononucleotide) with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.